Every one of those 1 sits in a single category, ipo. Jeffrey Cheah is most often covered alongside Sunway Group, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Jeffrey Cheah, all published on February 28, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Jeffrey Cheah
Every one of those 1 sits in a single category, ipo. Jeffrey Cheah is most often covered alongside Sunway Group, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Jeffrey Cheah, all published on February 28, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 2 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Jeffrey Cheah. Shared-story counts are live from our verified record — not editorial picks.
Sunway Healthcare, backed by Malaysian billionaire Jeffrey Cheah’s Sunway Group, is set to raise $736 million through an initial public offering to fund its ambitious hospital expansion plans. The move positions the provider to capitalize on rising demand for private medical services and medical tourism across Southeast Asia.
Jeffrey Cheah is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.